~ COVID-19 Medical News ~
~ On Cell Phones - Best Viewed in Landscape Mode ~
Medical News on therapies and treatments being investigated:
than 94% effective
Nov. 2, 2020 - New cause of COVID-19 blood clots identified
Sept. 9, 2020 - Hydroxychloroquine - The jury is in
July 31, 2020 - Merck aims to start ‘large pivotal’ studies on coronavirus treatment in
July 30, 2020 - Johnson & Johnson starts human vaccine trials after monkey study
July 28, 2020 - Pfizer/BioNTech makes surprise choice in final dash to October finish line for
July 27, 2020 - Watch "Pfizer CEO Bourla on coronavirus vaccine timeline
July 27,2020 - HERE WE GO: Virus Vaccine Put To Final Test In Thousands Of Volunteers
July 20, 2020 - COVID-19 vaccine hopes rise after strong trial results in England
July 16, 2020 - Asthma Medicine Hailed as Effective Treatment for COVID-19 and
Dr's Interview https://www.youtube.com/watch?v=eDSDdwN2Xcg&feature=youtu.be
July 16, 2010 - Johnson & Johnson hopes to begin late-stage coronavirus vaccine trial ahead of
schedule in September
July 14, 2020 - Covid Vaccine Front-Runner Is Months Ahead of Her Competition
July 14, 2020 - Merck CEO Frazier says COVID-19 vaccine hype a 'grave disservice' to the public
July 13, 2020 - Russia Completes Human Trials Of Covid-19 Vaccine
July 10, 2020 - TB vaccine might help fight coronavirus
July 10, 2020 - Gilead says Remdesivir coronavirus treatment reduces risk of death in severely
July 9, 2020 - First Seattle volunteer in human COVID-19 vaccine trials says she feels 'fantastic'
July 3, 2020 - European Commission has given conditional approval for Remdesivir use
following an accelerated review process.
July 2, 2020 - Hydroxychloroquine UPDATE - DETROIT MI - Henry Ford Health study finds
Hydroxychloroquine lowers COVID-19 death rate
June 30, 2020 - Hydroxychloroquine UPDATE - UK regulators - trial to restart
June 19, 2020 - San Diego biotech to test if medical device removes coronavirus from blood
June 18, 2020 - Blood types may play role in which COVID patients get sickest
June 17, 2020 - San Diego Researchers Develop Mini ‘Sponges’ That Could Stop Coronavirus
June 16, 2020 - Dexamethasone proves first life-saving drug
June 15, 2020 - Israeli researcher: Antiparasitic drug could 'cure' coronavirus
June 15, 2020 - Hdroxychloroquine UPDATE
FDA pulls emergency use authorization of hydroxychloroquine for COVID-19
June 11, 2020 - Regeneron Pharmaceuticals Inc.
US human trials begin for first antibody cocktail that might treat and prevent Covid-19
June 11, 2020 - Moderna to start final testing stage of coronavirus vaccine in July
June 10, 2020 - Johnson & Johnson says coronavirus vaccine's human trials moved up to July
June 3, 2020 - Hdroxychloroquine UPDATE - WHO resumes hydroxychloroquine study for Covid-19
May 30, 2020 - Hdroxychloroquine UPDATE - Scientists Worldwide Are Questioning A Massive
Study That Raised Concerns About The COVID-19 Treatment.
May 27, 2020 - Hdroxychloroquine UPDATE - EU governments ban malaria drug for COVID-19,
trial paused as safety fears grow.
May 26, 2020 - Novavax begins human trials for COVID-19 vaccine in Australia
May 26, 2020 - Merck Chairman and CEO
May 21, 2020 - Dr.Paul Stoffels, Johnson & Johnson
Vice Chairman, Status of J&J's Vaccine
May 20, 2020 - New research shows that diabetes medications could treat COVID-19 in diabetes patients
May 15, 2020 - Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") announced today that its anti-SARS-CoV-2 antibody, STI-1499, demonstrated 100% inhibition of SARS-CoV-2 virus infection in an in vitro virus infection experiment at a very low antibody concentration.
Hdroxychloroquine - An old (since the 1930's) anti-malarial drug is now in clinical trials all over the world and has shown to be effective in eliminating the COVID-19 virus from the body. BUT only time will tell if this drug will be a true effective solution until a vaccine can be fully developed.
That said, Teva says it will donate 6 million doses of hydroxychloroquine sulfate tablets
tablets through wholesalers to hospitals by March 31. We expect them to be widely
available in mid-April.
May 14, 2020 Update - NIH begins clinical trial of hydroxychloroquine and azithromycin
to treat COVID-19
* * The projected time for a fully tested vaccine is Spring of 2021. * *
Remdesivir has been studied for years as an experimental antiviral, most recently for its potential against Ebola. Doctors were throwing it against COVID-19 in a "try something" approach, to the point that demand led its manufacturer, Gilead (GILD), to limit its used to clinical trials. Six large studies are ongoing. The first should report results on April 3, the second in mid-April, and two more in May.
UPDATE - May 2, 2020 FDA Approves Emergency Use
Convalescent plasma, blood plasma from patients who have recovered from the virus, with their antibodies in it. Still in research, availability at least nine months away. Artificial antibodies, which are similar to blood plasma but more consistent. Trials should begin in early summer, availability possible in the early fall.
April 30, 2020 University of Oxford - Vaccine 'could be ready by end of year'
May 18, 2020 Early data show Moderna Covid-19 vaccine generates immune